Izotropic Corporation (IZOZF)
USD 0.03
(-10.45%)
USD 0.03
(-10.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 2.04 Million CAD | 2.26% |
| 2023 | 1.97 Million CAD | 1050.03% |
| 2022 | 171.58 Thousand CAD | 104.22% |
| 2021 | -4.06 Million CAD | -562.31% |
| 2020 | -613.57 Thousand CAD | -98.89% |
| 2019 | -308.5 Thousand CAD | 34.63% |
| 2018 | -471.94 Thousand CAD | -1255.79% |
| 2017 | 40.83 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.01 Million CAD | 5.11% |
| 2024 Q4 | 2.04 Million CAD | 1.65% |
| 2024 FY | 2.04 Million CAD | 3.71% |
| 2024 Q2 | 1.91 Million CAD | -2.22% |
| 2024 Q1 | 1.95 Million CAD | -0.72% |
| 2023 Q1 | 601.7 Thousand CAD | 250.68% |
| 2023 Q3 | 1.71 Million CAD | 50.44% |
| 2023 Q2 | 1.14 Million CAD | 89.84% |
| 2023 FY | 1.97 Million CAD | 1050.03% |
| 2023 Q4 | 1.97 Million CAD | 14.83% |
| 2022 Q2 | -2.65 Million CAD | 26.36% |
| 2022 Q4 | 171.58 Thousand CAD | 111.59% |
| 2022 FY | 171.58 Thousand CAD | 104.22% |
| 2022 Q1 | -3.6 Million CAD | 11.39% |
| 2022 Q3 | -1.48 Million CAD | 44.18% |
| 2021 Q1 | -226.45 Thousand CAD | 63.09% |
| 2021 FY | -4.06 Million CAD | -562.31% |
| 2021 Q3 | -4.6 Million CAD | -47.52% |
| 2021 Q4 | -4.06 Million CAD | 11.78% |
| 2021 Q2 | -3.12 Million CAD | -1278.9% |
| 2020 FY | -613.57 Thousand CAD | -98.89% |
| 2020 Q4 | -613.57 Thousand CAD | -924.84% |
| 2020 Q3 | -59.87 Thousand CAD | 44.12% |
| 2020 Q2 | -107.13 Thousand CAD | 59.0% |
| 2020 Q1 | -261.32 Thousand CAD | 15.29% |
| 2019 FY | -308.5 Thousand CAD | 34.63% |
| 2019 Q2 | -385.84 Thousand CAD | 27.22% |
| 2019 Q4 | -308.5 Thousand CAD | 12.74% |
| 2019 Q1 | -530.17 Thousand CAD | -12.34% |
| 2019 Q3 | -353.55 Thousand CAD | 8.37% |
| 2018 Q3 | -583.56 Thousand CAD | -33.29% |
| 2018 Q2 | -437.81 Thousand CAD | -392.97% |
| 2018 Q4 | -471.94 Thousand CAD | 19.13% |
| 2018 FY | -471.94 Thousand CAD | -1255.79% |
| 2018 Q1 | 149.44 Thousand CAD | 265.98% |
| 2017 FY | 40.83 Thousand CAD | 0.0% |
| 2017 Q4 | 40.83 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 7.229% |
| Arrayit Corporation | 1.05 Million USD | -93.878% |
| Atlantic International Corp. | 236.49 Thousand USD | -765.358% |
| Biocept, Inc. | -788 Thousand USD | 359.713% |
| Bioqual, Inc. | -12 Million USD | 117.044% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -8900.123% |
| DermTech, Inc. | 17.65 Million USD | 88.407% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.357% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 127.742% |
| iMD Companies, Inc. | 1.11 Million USD | -83.396% |
| IDenta Corp. | 524.85 Thousand USD | -289.927% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 73.401% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 7693.27% |
| InVitro International | -313.14 Thousand USD | 753.55% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -30.693% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 287131.978% |
| Medical Imaging Corp. | 3.79 Million USD | 46.015% |
| NovelStem International Corp. | 3.52 Million USD | 41.885% |
| Optigenex Inc. | 8.93 Million USD | 77.093% |
| PharmChem, Inc. | -1.49 Million USD | 236.946% |
| Proteome Sciences plc | 14.57 Million USD | 85.957% |
| Response Genetics, Inc | -13.08 Million USD | 115.639% |
| Rennova Health, Inc. | 14.82 Million USD | 86.2% |
| RushNet, Inc. | 4.8 Million USD | 57.371% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -1409.369% |
| Stella Diagnostics Inc. | 6.19 Million USD | 66.954% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -14.691% |
| Todos Medical Ltd. | 38.31 Million USD | 94.659% |